CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

NCT00526643 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
57
Enrollment
OTHER
Sponsor class

Stopped scarce enrolment and presentation of positive results of similar study in June 2012.

Conditions

Interventions

Sponsor

National Cancer Institute, Naples

Collaborators